Fortress Biotech Inc

NASDAQ:FBIO   3:59:59 PM EDT
3.54
0.00 (0.00%)
4:50:07 PM EDT: $3.54 0.00 (0.00%)
Other Pre-Announcement

Fortress Biotech Q2 Loss Per Share $0.04

Published: 08/16/2021 20:10 GMT
Fortress Biotech Inc (FBIO) - Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights.
Q2 GAAP Loss per Share $0.04.
Q2 Revenue $17.8 Million Versus Refinitiv Ibes Estimate of $14.7 Million.
Q2 Earnings per Share Estimate $-0.13 -- Refinitiv Ibes Data (analyst estimates).
Rolling NDA Submission for Cutx-101 for Treatment of Menkes Disease Expected to Begin in Second Half of 2021.